remember, regeneron jumped into this very early. they got into the game very early in terms of trying to develop a therapeutic against covid. that's why they have an advanced product at this point in time. they've had a lot of discussions with the white house they've been working closely with operation warp speed to try to get more manufacturing capability for that drug i doubt that played a role in making a decision on the clinical circumstance of what was the most appropriate drug for the president. regeneron does seem to have very promising data if you wanted to go down the route of using an antibody up front, that was a natural choice it might not be a bad choice because it reserves the ability to still use the anti-viral drug even pretty soon if you want to. i mean, the president could potentially be dosed with remdesivir if they want to provide an anti-viral in conjunction with an antibody drug there shouldn't be any reason why one therapy should obviate the other. these should be synergistic. >> going back to your conversatio

we are talking about the regeneron antibody cocktail. one of the things you suggested is in extremis drug that has been tried out with some promising results and nope side effects. do use and expend mental drug on the president, is that safe? >> one of the things you have to remember is that there are not any fda approved drugs. most of the drugs being used are being used under an fda emergency use authorization or on in extremis a basis -- experimental basis. there is not of the full backing that you have for most other types of medicine. i will go out on a limb and guess the president gets a slightly different than standard medical care than the rest of the country. i am not a physician, but i imagine having the president may be a different experience than some of the rest of the patients a physician sees in the day-to-day practice of medicine. don't knowt we still are some of the exact details of his condition. bit more, does the use of this regeneron therapy imply everything -- anything about the president underlying condition or is

the president has received the high dose of this cocktail that regeneron tested in its trial. we'll see how he does. we're also remind you that even though this is the first trial we've seen for the coronavirus with this approach, regeneron developed a similar drug of three antibodies it put together for ebola and in a clinical trial in africa, it did show that it saved lives. so there is precedent for using this medicine or this approach >> meg, thank you. mega t we have some breaking news on the status of president trump. let's get straight to shepherd smith. >> thanks. we just heard from the white house doctor a short time ago about that regeneron antibody cocktail that you mentioned. nbc news is further reporting that the president has a low-grade temperature and has for the better part of the afternoon at least and that he is fatigue d, according to his doctor, but in good spirits. a couple of lines within the memo from the doctor at the white house are of note. as of this afternoon, it reads the president remains fatigued but in good spirits. it goes on, he's being evalu

they need to take a couple of regenerons. >> they do get me some of that regeneron. >> get some regeneron on the way in and there i'll be on mrs. toad's wild right in a heart beat. >> that and some steroids and you're good to go. >> got rid of that ride a long time ago >> i think sometimes these kids are marketing opportunities for the so-called activist in question talk about them, maybe thens their assets i think third point had -- their cio left, had trade, they had some things, i think the firm is up a bit this year again, i doubt this goes very far. but we'll see. and, listen, in the marketplace of ideas, always interesting to discuss ideas like this, that they do bring up in this letter that was sent again on october 7th and made public yesterday to mr. chapek we haven't gotten to morgan stanley meeting vance. >> why did we decide it black list that? >> i don't know. >> isn't it coming on later today? >> i guess he is, yeah we're talking about james gorman that man is on a mission >> to reinvent the company and -- >> the e-trade deal last week. >> don't want to be citigroup. >> oppo

and within a very short period of time, they gave me regeneron. it's called regeneron. and other things, too. but i think this was the key. but they gave me regeneron. and it was like, unbelievable. i felt good immediately. >> pelley: we don't know why mr. trump settled on the regeneron antibody therapy as his 2017 financial disclosure form, regeneron is listed as a but need in his 2020 disclosure. ( cheers and applause ) what did your colleagues here learn from treating you? >> dr. pruden: one of the things i've learned, they learned, is not to give up. ( cheers and applause ) >> pelley: dr. james pruden, director of emergency preparedness at st. joseph's in new jersey, was released after 33 days. he had to learn to walk again in physical therapy. >> dr. pruden: it felt like love. and you never knew so many people cared. you know what i mean? that it was important to them that you come out. that's what it felt like. >> pelley: dr. pruden, and others, told us the medical community is much better prepared now in case of another surge in the fall. >> dr. pruden: we're a l

obviously, i understand what regeneron and got the headlines. one of your competitors upgraded the stock $690 price target on the back of a completely different drug for a completely different thing. i see the headlines. it's more about other things that they have that are out there and working, isn't it? i think those are the reasons why you want to stay with a name like regeneron >> so i wouldn't necessarily disagree it's been a great drug p it's a profitable endeavor but it was the same as it was a year ago when the stock was trading at $300, vhalf the valuation. i don't think there is a huge dynamic change when it was $300, i was much more positive on the stock it's ridden a lot on the vud thesis and, you know, i think it's fair to say a lot of these names have not really supported long term valuation from covid-19. it has sort of been a temporary trade. and, look, maybe this will be the drug and i'll be wrong and we'll see some full randomized control data and this will be the drug that really drive profitability for regeneron. you look at

, too, but i think this was the key, they gave me regeneron, and it was unbelievable. i felt good immediately. we have medicines right now, and i call them a cure. i went into the hospital a week ago, i was very sick, and i took this medicine and it was incredible. it was incredible. i could have walked out the following day. we're going to make them available immediately. we're taking care of our seniors. you're not vulnerable, but they like to say the vulnerable, but you're the least vulnerable. but for this one thing, you are vulnerable. >> trevor: ah, it's always

of regeneron, dr. leonard schleifer, who joins us from rochester, new york. >> good morning, margaret. >> brennan: good morning. so president trump was given this cocktail, and he has since said it was both a cure and he is now immune. does your drug cure covid, and does it make you immune? >> so the president's case is a case of one. that's what we call a case report. it is evidence of what is happening, but it is kind of the weakest evidence you can get, although there are some very interesting aspects of his case. such as he was elderly, he had some risk factors, and he did not have his own immune system in a year when had was sick and he got treated with our immune system in a vial, if you will. but the real evidence has to come about how good a drug is and what it will do on average -- has to come from these larger clinical trials, which are the gold standard. and those are ongoing. we have sommary evidence, and we're going for emergency use authorization because we think it is appropriate at this

regeneron. it was like unbelievable i felt good immediately. i felt as good three days ago, as i do now. >> first of all, regeneron sounds like a name a movie would use for regenerated dinosaurs.ge here at regeneron industries, we ar are making clones -- the clones are rising up. turn them off? i don't know -- statict pay fo they wouldn't pay for the second camera and it could be a major breakthrough, the president shouldn't be talking about it like he is filming a prescription drug commercial all that is missing is him playing on the beach with other 70-something >> when you get to my age, physical intimacy can be a struggle that is i didn't take regeneron. i can't find nigh intimacy pills.regeneron. i can' you flushed them down the toilet mel, i can't be intimate i love you mel i am not mad mad >> miracle cures, during his $100,000 hospital stay the administration is in court trying to take healthcare away from million, which they will get when they get their supreme court majorityy get their supre court majority raccoons i heard. i heard. [c

but the regeneron, was i view it as a cure not just a therapeutic eli lilly has great drug i spoke to the head of the company very much along the lines, of regeneron, and they work in a very similar way. the it is great. and what i am doing, is i am going to supply this drug -- it made me better i will tell you right now walked in didn't feel great, i think i would have done it fine without drugs, you know, don't really need drugs, they also like to give you steroids like a storied combination for -- because that stop the swelling, like a baseball pitcher would use a storied when his arm blows up want to stop swelling of the lungs in particular. and so they gave me a storied which is very easy thing to take, but no, i had tremendous luck with this regeneron, and eli lilly would have had luck what i am doing i don't know if you saw video i made last night. maria: a i did you said -- blessing in disguys. >> i can't be like biden enhancing out in a basement if i wanted to hang out in a basement i wouldn't catch it i meet lot of people i have to i am president of the country can't hang ar

is effectively is a cure regeneron is effectively is a cu re stop regeneron is effectively is a cure stop it is worth remembering that regeneron is an experimental drug, only a handful of people have been at it. he was given it for compassionate reasons. it has not been approved by federal regulators. he is on but if you other x—ray mental drugs, including heavy steroids so we are not quite sure why he thinks it is regeneron that has made him feel better. there are still questions about how healthy donald trump is because there has been a huge confusion about the state of his health but it allows him to show not only that he is on top of the pandemic that he survived it. he wants to show that he knows what he's doing. the figures speakfor what he's doing. the figures speak for themselves though stop more than 211,000 people have died here in the us, 7.5 million people infected with coronavirus and at the numbers are going. going by appearances, he is raring to go but we do not know if it is the drug awaken, if he was not as ill but also this question, how long has he had the virus?

we hear that he took the regeneron cocktail. and we hear overnight that he also got his first dose of remdesivir. the regeneron is not approved by the fda. it's aexperimental. do you have any concerns about the president taking both of these drugs in concert. >> yeah. we don't have a lot of data on using those two together. although there's a lot of experience now with remdesivir, used with convalescent plasma. so we don't have good safety data of the two together. i think there's a high likelihood it's probably safe. i think, you know, the president's doctors were in a tight spot, because the president does have high-risk factors as everyone is talking about, due to age and the fact that he's male and co-morbidities including being overweight. so, we know he's very high risk of having severe illness, even dying. so, you've got to make a decision on what's the best approach given the national security interest of the country. and the issue with both the monoclonal antibody and the remdesivir, they would only work in the early co

what they've accomplished up at regeneron. one thing i want to make clear if you're the president's doctors you would throw everything at this, particularly if the current profile especially if it hasn't indicated any side effects the man is in the at-risk category they're going to do everything they can and i don't know if you can second guess what's being given to him, carl i just don't think you can >> i know. over the weekend said it's clear they kind of thrown the kitchen sink but the president, seems to be defying all kinds of expectations given the cdc data for patients who have been in his age group with underlying conditions you mentioned the doctor this morning and he was asked on "squawk box" the degree which he thinks it helped the president >> early on in the course of this disease the virus can get ahead of the immune system and we think giving that antibody makes a lot of sense because it is doing what the immune system is supposed to do but hasn't quite done yet that's what we hope happened with the president y

with regeneron and infusion therapies, they're not every day, i guess that. what do you make of the strategy they're using here? >> no, they're-- the physicians said, they're following the protocols so they're giving him remdesvir and they'll keep doing it the course of five days, of course. so and he has been responding very well to all the medication that they have given him so far because he told us that he had fever and now he doesn't have fever. so for me, that was a good sign that the regeneron is working in that regard. so the question i would have loved to be answered is when somebody asked is he on steroids and the physician didn't answer, but that's very important and will be telling if he's on steroids or not because it means that the body is defending much higher than it should and would like to slow it down when that's the case. neil: doctor, when i'm hearing that they're going to look for the next five days, treatment, let's say for the remdesvir, that would seem to indicate he's going to be at walter reed for at least another five days, right?

regeneron isnk something that should give us hope. these are synthetic antibodies that are derived from people who have recovered and then the best ones are put into a synthetic form. this is something we have seen be instrumental in controlling bolo. you may remember -- ebola. you may remember zmap. this is something we have turned to her infectious diseases. right now the regeneron product, as well as the eli lilly product are in trials. her symptoms, and maybe can prevent you from needing to be hospitalized. they have been filing for emergency use authorizations, so this might be something that becomes more widely available. all of us want to see the clinical data to know how well it works, who it works in, when it works. it seems the president had a good experience, we obviously cannot generalize from a sample size of one. coupling what his experience was with what we have seen in trial data, it does look like something that may be a bridge before we get a vaccine. that we have a treatment that may be able to change the game with

. >> shares of regeneron trading higher once again this morning company announcing that it has filed an application for a emergency approval of its experimental antibody cocktail to treat covid president trump received that treatment and in a video late yesterday, he hailed it as, quote, a cure. facebook says that it will stop running political ads in the u.s. for at least one week after the polls close on election day. the change comes as the company looks to stop the spread of misinformation on its platforms, including the premature calling of election results. and samsung says that its earnings likely rose 58% in the last quarter, that topped estimates by quite a bit among drivers, a rise in smartphone sales and also benefiting from u.s. restrictions on huawei got to admit, i'm definitely an ios person i've tried the android, but somehow i wound up with iphones. >> if you got your photos and the music and all the apps you already maybe bought and all your stuff, how are you ever going to change. >> and i -- my brother swears by android. he is android all the way. i don't know one

he was getting that regeneron antibody cocktail. this is an experimental drug and you only saw the first data on tuesday of last week, three days before then friday evening he had also been started on a five day course this is the antiviral drug that is clear for covid-19 and is commonly used. saturday we were told he started dextamethazone that does signify he is in a more severe state of the disease than we realize. at the same time, his doctors told us his oxygen level dropped to 94% or less twice over the previous couple of days. doctors i have spoken with says that does mean that the president is categorized as having severe covid-19 that's when the latter two drugs make sense typically they are given -- well, they are always given in the hospital and indicated for more severe patients what do the clinical trial results tell us about all three of these drugs first, the first thing he got -- sorry, we're showing it in a clinical trial that it reduced mortality by a third of patients on ventilators and they said that it could cau

but with president trump last week getting the regeneron treatment, that's been pushed back into the spotlight and they both applied for emergency use this week. before investors jump in to these types of names i think it's important to understand what you're investing in. both the regeneron and eli lilly drugs, they're both monoclonal antibody drugs they're both only useful for covid-19 patients who have seen less severe cases and specifically early on, similar to what president trump was seeing when he received this treatment. so it's important to understand that these are not vaccines. they're not useful right now for prevention purposes, even though both regeneron and eli lilly have started clinical trials to see the efficacy of using them as a preventative measure. however, the efficacy so far has been fairly strong in both clinical trials, so far eli lilly has seen about a 72% reduction in risk, meaning the number of patients that are seeing hospitalizations compared to a control group is 72% less than for regeneron. it's a small sample size, it's down 59%. so both of these hav

[habla en inglÉs] reportero: el regeneron sea una cura como insiste el presidente. el consenso entre muchos que la terapia ofrece una promesa. pero usarla en la poblaciÓn es prematuro. >> no tiene sentido, realmente ridiculo y no tiene sentido. tenemos que dejar que la ciencia haga lo que tiene que hacer. no estamos dejando que eso pase. reportero: mientras tanto toda la atenciÓn que recibe regeneron hace aumentar sus acciones. ilia: el secretario de salud y servicios humanos dio a conocer hoy que el paÍs estÁ haciendo todo lo posible para asegurar que haya suficientes vacunas contra el coronavirus para ser aprobadas. y que podrÍa haber cien millones de dosis. la cifra serÍa suficiente para cubrir a poblaciones vulnerables como ancianos y al personal mÉdico. agregÓ que para marzo o abril del 2021 se proyecta tener suficientes vacunas que alcancen para cada estadounidense. la revista publicÓ un editorial en el que critica la administraciÓn trump por su respuesta a la pandemia del covid 19. pide que pierda su puesto en las elecciones. el editorial seÑala qu

and within a very short period of time they gave me regeneron. it's called regeneron. and other things too but i think this was the key but they gave me regeneron and it was like unbelievable. i felt good. >> reporter: the president releasing this video from the white house. >> i want everybody to be given the same treatment as your president because i feel great. i feel like perfect. >> reporter: trump's chief of staff reassuring the public that the oval office is taking precautions. >> we've got safety protocols there that are not only from the ppe standpoint but from a ventilation standpoint. >> reporter: but the white house now facing unprecedented criticism from the prestigious "new england journal of medicine" over the administration's handling of the pandemic writing in a scathing editorial that u.s. leaders have taken a crisis and turned it into a tragedy. 32 states and territories are now seeing a rise in covid cases. some areas of the country are now facing new closures and restrictions. anger erupting in new york city as hundreds of orthodox jewish men set f

regeneron is going to go for emergency approval, and that stock is up a lot. we'll let you comment on all of that, lloyd, but my overarching question, that is, every ten years, it seems like the financial system needs a bailout. we need a different financial system my question is about capitalism in general you're supposed to put your money down and risk it on an idea, knowing you can make it big or lose it big if we keep making it so that you don't lose, it just seems like things, you don't get real market prices. it's almost like everything is fake you can't trust the price discovery on anything you're doing, whether it's debt or whether it's, you know, equity or whatever it is. when does this really finally, okay, now it's covid, before it was the housing crisis before, you know, it was snl, i don't know whatever it is, but when do we finally say, look, you need to lose, and suffer the consequences or else it's not going to work anymore! look, if you have to lose, it's better that you lose at a time when everybody else is losing. and at a really tough time

how far are we away from widespread availability of regeneron, that antibody treatment? >> i'm hopeful about this treatment for the future, but we have to be cautious about preliminary data. we have not seen it in large peer reviewed clinical trials. there is no breakthrough that i see yet. i'm hopeful we'll have more information in the future. >> regeneron's ceo also cautions that the president's antibody cocktail is only one case report. he also says there are limited doses available. >> we'll keep an eye on that. >>> coming up, remote working. we're check out new gadgets to help take a little of the work out of your work from home. help take a little of the work out of your work from home. says there are limited supplies available. >>> coming up, remote working. >> gadgets to take a little of the work out of your work from home. ♪ o on ♪ >>> welcome back. 2020 means working from home or living from work depending on how you look at it. luckily this morning we're checking out some gadgets to make that home office setup a bit more user friendly. the giz wiz dick dib

within a short period of time, they gave me the general on, it is called regeneron. in other things too, but i think this was the key. they gave me regenerate on and it was like unbelievable. i felt good immediately. i felt as good three days ago as i do now. and so i just want to say we have regeneron and a very similar drug from eli lilly and they are coming out and we are trying to get them on an emergency basis. we have authorized it, i have authorized it. and if you are in the hospital and feeling really bad, i think we are going to work it so you get them and get them for free. especially if you are a senior, we will get you in there quick. we have hundreds of thousands of doses that are just about ready. i have emergency use authorization all set. and we have to get it signed now. and you will get better. you are going to get better really fast. this is thing that nobody thought of a few months ago. the jobs that the scientists, the labs come everybody up done is incredible. in addition to that, you have other drugs that help a lot but i view these they call t

i think it was regeneron that was responsible for it. because of that, it was sort of like almost a gift from heaven because, because of what i went through -- and i had, you know, i felt pretty lousy. a lot of people did. a lot of people do. you know, no mart how good the security, you're not going to protect yourself from this thing with just your standard anything unless you just literally don't come -- even those people found out. did you see in new york city the most heavily locked down place, the people that caught it the most were the people that were caught in their houses and their apartments, okay? maria: well, you know -- >> it's one of those things -- yes, go ahead, maria. maria: i'm glad you brought up new york, mr. president, because yesterday andrew cuomo, the governor of new york, said that the city is going to be on lockdown until november 3rd. not november 2nd, november 3rd. which, of course, is election -- >> they're trying to hurt the economy as much as possible, the democrats. this is where they figure the economy wi

dose of regeneron's experimental antibody cocktail. meg tirrell joins us now with a special guest, meg, and should be interesting whether mr. leonard schleifer would attribute some of the president's good reaction, going better today, i wonder if that has in len's view, something to do with the cocktail maybe we should ask him. >> perhaps we should, joe, doctor, thank you for being with us this morning. joe asks a good question can you tell us how the antibody drug aims to help the virus, and given what we have heard about the president over the weekend, do you think it's work something. >> thanks, meg, joe, for having me on. before i start, let me say how proud, team regeneron, all of our employees are to have worked so hard to get to a point where we can help the president and hopefully many other people, and that hard work was done right in the epicenter of the pandemic in the early going, where our main headquarters are in new york look, we think that this is nothing particularly earth shattering in its perspective. that is we're j

i had the regeneron. i don't know what would have happened without the regeneron. all i know is i had it and i was better within 24 hours. i felt perfect. >> that was president trump this morning during a phone interview on the fox business network, that was rife with a lot of medical misinformation. he said the heavy steroid is not a heavy steroid, doesn't think he's contagious and dr. fauci said can only be proven in a lab. >> you can definitively show that by another one of the recommendations that had been made about two negative pcr tests 24 hours apart. so if the president goes ten days without symptoms and they do the test that we were talking about then you can make the assumption based on good science that he is not infective. >> here with his perspective is vaccine expert dr. peter hotez. dr. hotez, so let's talk about this cocktail from the company regeneron and we heard what the regeneron -- what the president kept saying there. what is it, and when would you be convinced that this is an effective treatment? >> so, chuck, now there are two cocktails. th

in terms of the regeneron, i want to end on the regeneron. it looks very, very effective in multiple trials, regeneron and they've been testing it and poor people and people in minority communities, so the president says he's going to offer it for free to those communities. hooray, that is so charitable, but he also at the end of his talk tonight appealed to a higher force, tucker, that we all must appeal to, which is god. tucker. >> tucker: dr. marc siegel, thank you so much for that. we've heard a lot from the media about how you can't criticize kamala harris because she's a woman. if only the majority of americans are. no criticizing her. we've heard almost nothing about what she believes. her record on illegal immigration, her stated positions on the topic. ahead of tonight's debate, we will tell you where she stands on that and a bunch other issues. we will be right back. ♪ ♪ ♪ ♪ ♪ (clapping) ♪ hey, you alright? ♪ find the nonpartisan facts behind the real stories at usafacts.org ♪ >> tucker: so the vp debate is about to

look, the data on regeneron is coming from a press release not a study from an esteemed journal. the average age was 44, and the makeup of that population was majority from the black and latino communities, which is great that that representation is there, but in terms of generalizing that to the rest of the american public, that just -- we can't use that as a way to assume that this is going to be this miracle treatment, which again, as we've already said, it likely will not. >> it's a therapeutic, not a cure in any case. as you know, the antibody cocktail from regeneron has been given only to ten people inside the u.s., outside the clinic trials, has not been approved not yet anyway. would you feel comfortable prescribing it on a large scale based on what you know now? >> all we know is from a press release and investor pamphlet sent out from some of the data. we don't have any good scientific backing that we would like to see to know if we should be using it more. i wouldn't be surprised if it gets an emergency use authorization from the fda. the bar for that is actually prett

oz is with us.in regeneron, remdesevir, steroidal inhalers. dare i even say the word, words hydroxychloroquine with zinc. i guess the jury is still out in some people's minds. they seem to be the four major therapeutic breakthroughs. your thoughts on what the president has done especially with regeneron and remdesevir. >> i've got the chief scientific officer of regeneron on the show tomorrow. he is a columbia alum. we were talking about this 30-year history. it's not an overnight success. they've been working on this technology. basically it's a antibody cocktail. i made an animation that i think can explain regeneron, also remdesevir and dexamethasone. there you are. those virus particles. that's what the cdc says can be aerosolized. there it is getting into the president's nose, it happened about a week ago, through his trachea and lungs. the virus particles try to attack our cells. regeneron blocks the particles from latching onto those iereceptors. the antibodies getting the body's immune system a chance to recover. survivors replicates a

and for regeneron, down about 59%. so both have fairly strong trials at the moment it's important to look at this the optimism around it is the efficacy and the speed we could get fda approved for emergency use. but there is limited capacity. so that is a limiting function when you couple that with the chart, eli lilly has been underperforming the broader market the last few months but on this recent fda news, it has broken out and broken that down trend and we are starting to see performance when you couple that, what i am looking to use as a trade structure going out to december to buy myself a little bit of time and i am going to use a vertical spread -- i am going to december and spending about 8.70 for that december 155. i have a target price of about 170 to the upside. if they do break out in the short run, i would try to roll this up a little further into that 170, 190 level if we do get a breakout, up to that 170 target >> that's an interesting way to go about playing it and cheap e ens things up a bit. does to

maldonado with stanford talking about the latest with president trump and the regeneron trial. by the way, you can see the deba >>> tonight, several developing stories as we come on the air. we're just hours away from the big vp debate, as president trump breaks isolation, returning to the oval office, despite his infection. and the president posting video moments ago from the rose garden. earlier, a marine standing guard as the president receifi si. two s of the president's ner ci with him. the white house insisting tonight safety procedures are in place. in world if the president is still taking the powerful zbgi reed. >>> all of this as we are just hours away now from tonight's vice presidential debate showdown. the stage set. the two will now be more than 12 feet apart, separated by those plexiglass shields. the

the company, regeneron that created the treatment only started using this cocktail in june. but so far, it's said to be safe. regeneron's ceo leonard schleifer spoke to chris compuoa couple hours ago. >> his life is not seriously threatened right now. from what we hear, and i hear the name news you do. but he's a patient at risk and he felt they wanted to tilt the odds. what we found, we can help the patient's immune system, by basically giving him an immune response in a vial, sanjay has it's almost right. and he covered so many different areas. they're proteins, not cells. they're monochrome cells. to help you win that race. >> regeneron hopes the fda will authorize the drug for emergency use. there are right now 70 different antibody treatments for covid-19 under investigation. >>> there's still so many things we don't know about the president's condition for the treatment he's receiving. dr. saju mathew is here with us. doctor, glad to see you, it's an experimental treatment. we just heard from the ceo there. do you as a doctor have any concerns about treating the presid

the regeneron therapy indirectly relied on tissue taken from aborted fetus. trump whose base is against abortion rights has worked to reverse health policies from the obama era, including those that forwarded scientific research involving human fetal tissue. brian todd, cnn, washington. >> it's not just the united states that's seen cases rise. many countries across europe are tightening restrictions as their numbers spike. the paris region of france is mobilizing an emergency plan to deal with an expected flood of covid-19 patients. in britain, the health secretary is warning that the country is at a perilous moment. that country reported more than 17,000 new cases on thursday. and italy also has seen another jump, the largest daily increase there since the height of its first wave in april. we have reporters live across the continent this morning in paris, rome and london. but i'd like to begin in the french capital where melissa bell joins me live. the situation across the country in key cities is worse skpning now i understand some new restrictions in mor

an injection of regeneron. data suggest not just anecdotal success with president trump but fewer hospitalizations and fewer complications, especially in more vulnerable populations. president trump benefited from the antiviral cocktail. these drugs can also rescue patients when vaccination does not work or treat those who get sick after declining to be vaccinated. both gottlieb and mcclellan point out that this is far from a qr, but regeneron says it could have 300,000 doses by the end of the year. >> immersion >> emergency use authorizations set and you are going to get better really fast. to me, it wasn't therapeutic. it just made me better, okay? i call that a cure. >> "the new york times" reported the regeneron treatment was developed using cells from a fetal tissue. they didn't use human stem cells are embryonic stem cells in the development. >> shannon: thank you. four young friends, good news for you tonight. the 22 girls after going through cancertreat. three of them for leukemia. they reunite every ye

. >> we have some news on regeneron. let's get details. >> we had already seen initial data on regeneron suggesting that it worked to lower the load in patients recently diagnosed with covid-19. we are seeing more from this clinical trial for 800 patients overall with recently diagnosed covid-19, the study is showing this drug reduced the risk of needing to go to the hospital or have other medical visits by 57% compared to those with pla seebz. with patients in higher age, other body risks, the drug reduced the risk by 72%. if you could reduce the risk by treating people early by 57 or 72%, that would be a big difference in the disease. the problem is regeneron only has 57,000 doses right now they are waiting for approval by the fda and are ramping up for production to get to 300,000 in the next few months. >> this is the same antibody treatment for hospitalized patients, no >> this does not have emergency use authorization at all this is the cocktail the president was treated with this is for people who have not been ho

both the regeneron and eli lilly drugs, they're both moan know clonal antibody drugs. they're both only useful for covid-19 nationalities have seen less severe cases, and specifically early on. so it's important to understand that these are not vaccines. they're not useful right now for prevention purposes, even though both regeneron and eli lilly have started clinical trials to see the efficacy of using them as a preventative measure. however, the efficacy so far has been fairly strong in both clinical trials, so far eli lilly has seen about a 72% reduction in risk, meaning the number of patients that are seeing hospitalizations compared to a control group is 72% less than for regeneron. it's a small sample size, it's down 59%. so both of these have fairly strong trials at the current moment. so it's important to take a look at this, because the optimism around it right now is the efficacy and, more pouimportant, the speed at which these treatments could get fda approval for emergency use. however, both of these treatments have limited production capacity, so that is

had an upset stomach, take a regeneron. let's give him credit he didn't say he took a couple of cocktails. >> s&p not far behind. we're back after a couple of moments. this is decision tech. find a stock based on your interests or what's trending. get real-time insights in your customized view of the market. it's smarter trading technology for smarter trading decisions. fidelity. ♪ you may not expect the unexpected, but you can certainly take it all. the lexus es. wow, this rain is bananas. now available with awd. lease the 2021 es 250 awd for $359 a month for 36 months. experience amazing. at your lexus dealer. our retirement plan with voya gives us confidence... ...so we can spend a bit today, knowing we're prepared for tomorrow. wow, do you think you overdid it maybe? overdid what? well planned, well invested, well protected. voya. be confident to and through retirement. >>> take a look at some of the early gainers, xilinx on top, ge in there too as goldman reinstates with a buy, sees 50% upside, talks about larry culp

the first was a an experimental regeneron medication that he's been taking. friday he was to start the five-day course of remdesivir and saturday he started dexamethasone. that's for severe patients with covid-19 we learned the president's oxygen levels dropped low enough twice in the last few days that he would be characterized as severe, 94% or lower that's the nih guidelines. starting with the experimental anti-body cocktail from regeneron, we just saw the clinical trial results tuesday but it showed in that trial of non-hospitalized to reduce viral levels and improve symptoms. remdesivir shortened days from 15 to 11 and they found in the trial there could be possible harm in using the drug on patients who aren't far enough long to require respiratory support. >> as you said, meg, the oxygen level below 94% suggests that his symptoms at the very least and perhaps the virus were more serious than just a mild case that might not have required those more powerful drugs. the cdc, meg, updating some guidelines about how the virus spreads. what can you tell us >

the fda gave permission to use this regeneron cocktail. people are going to clamber and say, wait a second, if it is good enough for the president, it is good enough for me. wendy: i think there will be. if he does get that sort of drug and it's not available to the rest of us, to other 74-year-old obese men who catching the disease, then i think the public will be demanding some quick action. thank all right, wendy, you so much for your insight. we are continuing to follow the breaking news as it rolls in. we are waiting for president trump now to arrive at walter reed medical center. again, his doctors have said he is fatigued but in good spirits. going to the hospital out of abundance of caution, but will stay there for the next few days. i want to bring in our white house reporter, mario parker, who has been covering every move the president has made over the last week. first of all, give us the very latest that you are hearing from the white house. they have not raised any alarm yet, the fact he is going to the hospital. it does not m

navy and the president's position, the president received a single 8-gram dose of regeneron antibody cocktail a according to the memo in addition to that with antibody cocktail the president has been taking zinc and vitamin d, melatonin, daily aspirin and in terms of his condition, what the memo says is president trump remains fatigued and in good spirits, he's been evaluated by a team of experts at the moment but the language being used fatigue but in good spirits, as for the first lady she is said to be well with a mild cough and a headache. that is in from the white house, released by the press secretary. as we talk about all of this, we've been putting that in some context as a way you look at markets and investment and the volatility associated with this announcement from a president in this case president trump with a diagnosis of covid-19, and adds to political uncertainty we have plenty of that out there a month ahead of the election and try to put further context into the discussion, future file legacy planner and former investment banker in the market editor. doctor from jo

is this a silver bullet, the eli lilly cocktail, the regeneron cocktail? >> you know, we all want a silver bullet and it's unfortunately not. it is helpful. we shouldn't down play it. it is helpful. as dr. gounder said, with a couple hundred thousand doses and more than 50,000 americans getting infected every day right now, we would quickly exhaust the supply. so i wish that the government, the administration, had gotten serious about these antibodies and built up millions of doses of them so when they became authorized we could use them much more widely. unfortunately we're not going to be able to do that because we haven't had the proactive role from the federal government. >> there's been more than 50,000 confirmed coronavirus cases every day here in the united states. dr. gounder, you heard dr. anthony fauci calling out the trump campaign for putting him in this political commercial, this ad, with the remark that he says he was taken out of context and it was used totally without his permission. he doesn't get involved in politics. the white house has

yeah, i was enthusiastic about regeneron, and i'm also still enthusiastic about it and plasma therapy, though we don't yet have all the information we need to be certain that it works in all situations, and we may find that there are niches where it's most effective. we began the trials in new york, but as the pandemic moved on, we were unable to complete them there, so we've moved to brazil. now, we've been treating patients with very severe disease. thus far the data safety monitoring board which tracks what we do has not told us that we have an effect either so dramatic that either everyone should get it or no one should get it. so it's going to take a while yet, another few weeks before that trial is complete. even if we don't find a substantial benefit in people who are what we call sort of the hail mary pass when everything else has failed, it may still be useful in early disease. and i think this is what you saw this week. it's the implementation, the antibody therapy early in the disease. it's a function really of the way the antibody therapy works. it binds to the outside of

that's regeneron, but again, eli lilly has something similar. the kind of things we are coming up with now are incredible. remdesivir, but that's a little bit different, works much differently, actually. but these things are absolutely incredible. i think i'm going to try doing a rally on saturday night if we have enough time to put it together, but we want to do a rally probably in florida on saturday night. it might come back and do one in pennsylvania the following night and it's incredible what's going on. i feel so good. >> sean: have you had a test since her diagnosis a week ago? >> president trump: well, what we're doing is probably the test will be tomorrow, the actual test, because there's no reason to test all the time, but they found very little infection or virus, if any. i don't know if they found any, i didn't go into it greatly with the doctors. we have these great doctors at walter reed, but you do rely on them, they are really fantastic talents and they came in from johns hopkins also and other places. i saw so many doctors look

we are unsure as to what he thinks it is regeneron that has made them better, given that he is on quite a few other experimental drugs as well as a very strong steroid, and it's worth mentioning that even his own doctors and his medical tea m own doctors and his medical team have not explicitly said anything along the lines of what we have heard from him just now. the timing is indeed interesting, given that we have got the vice president of debates coming up and also the doctors have been speaking about him as well as having no covid symptoms for more than 2a hours. donald trump wants to show strength, he wants to show that coronavirus is something, as we heard there, that he has beaten, that he is in charge, he is back on form, and mike pence is the head of the coronavirus task force and i am sure that tonight, we will hear accusations that the administration has not handled this pandemic well at all, and so this does allow perhaps the administration to now suggest that they have got a handle off this pandemic, this pandemic continues to be a future issue that affects americans. more

, has, does that cause regeneron to think whether or not they should go forward? should president trump, who didn't take the eli lily cocktail but took the regeneral rock cocktail, should he be worried about his own health? >> usually when you see reactions to medicines like this, it's much more immediate. the president took this some time ago now. usually when you see reactions that would cause a pause in a trial, it's pretty immediate. you're typically not this long afterward. so i don't think the president would have reason, really, to worry about his health from what we know. as far as what regeneron would think, it's a really good question. these are not exactly the same. they're both antibody drugs, but they work differently, they use different antibodies. but certainly as the fda reviews both regeneron and lily, they'll say, wait, something happened with the lily one. someone got sick enough that they're concerned. i would think the fda would keep that in mind. they're both antibody drugs even though they are somewhat different. >> i certainly hope it's jus

what do you think about this regeneron antibody cocktail? >> the first thing i have to tell you, i saw a headline that the white house had more cases of coronavirus than all of taiwan. so i think they can be doing a better job about their case control. so regarding regeneron, it doesn't matter what the president said. it is not a cure. there is no fda approved cure for coronavirus. the antibody is a therapy. it's a treatment. it was in early phase clinical trials and it was shown to possibly reduce the amount of the virus in the body and the symptoms. that is a therapy. so calling it a cure is not factual. and saying it's accessible, that is not true. because it's not even fda approved yet. the president got it through use. you or i cannot run down to the nearest hospital, that is not how it works. >> okay. so it's clearly not a cure at this point. it may be a successful therapy. we still don't know. let's turn quickly as we turn to the race to the finish line to get a vaccine. several companies moving forward. even a couple -- they haven't

you asked about regeneron. i called the doctor. he's the person that has done a lot of the convalescent plasma work at columbia university. the president of regeneron is a columbia alum. he has a lot of insights that he shared with me. this is a very old approach. hundreds of years old roughly. the idea to take serum, the watery part of blood from people that already survived a virus but in this case covid-19 and give it to someone who is struggling. giving convalescent plasma gives you anti-bodies and other chemicals in the blood which is why it's promising. the fda has given the emergency use authorization for convalescent plasma. that's why we ask people to donate blood if they recovered from covid-19. and eli lilly harvested some of the antibodies directed against the spike proteins of the covid virus so they can prevent them from reproducing and growing in your body. let's say the president has an immune system that is slowly starting to catch up to the virus but hasn't got there yet. by attacking the virus before his immune s